Does liver enzyme ratio predict survival in sepsis?
Part of Infections clinical trials.
This study looks at whether the ratio of two liver enzymes (AST and ALT) in the blood can help predict survival in patients with sepsis or septic shock in the ICU. The goal is to find a simple way to identify patients who may need extra attention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 years or older) admitted to the ICU.
- You must have a diagnosis of sepsis or septic shock according to current guidelines.
- You must not have a pre-existing liver disease like chronic hepatitis or cirrhosis.
- You must not have a history of alcohol abuse.
- You must not be on high-dose statin therapy.
- You must not have other conditions that could raise liver enzymes, such as severe muscle breakdown or a recent heart attack.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether uric acid and lactate levels can help predict outcomes in sepsis patients aged 65 and older who are admitted to the intensive care unit. It aims to find better ways to monitor patients and guide treatment.
This trial tests whether a simple blood test (the capillary leak index) can help doctors better predict how sepsis will progress in people recovering from abdominal surgery. If you are in the ICU after surgery for an abdominal infection, this study may help guide your care.
This study compares two blood test measurements (neutrophil/lymphocyte ratio and lactate/albumin ratio) to see which better predicts how severe an infection is in ICU patients with sepsis. It aims to find a simpler way to track inflammation.
This trial checks if certain blood markers (CRP, CRP/albumin ratio, and neutrophil/lymphocyte ratio) can predict how well sepsis patients with normal blood pressure will do. It aims to help doctors better manage infections and survival.
This study looks at simple blood tests (like levels of certain white blood cells and a protein called procalcitonin) to see if they can predict how well people with sepsis will do in the intensive care unit. It may help doctors understand your infection better.
This trial looks at genetic markers to better predict sepsis after major abdominal surgery. It may help find patients at higher risk so they can be treated earlier.
Hear when a new E Prognostic Value of the AST/ALT Ratio Vs. APACHE II Score in Patients with Sepsis and Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.